Brittany Panico, DO
Rheumatology · Gilbert, AZNPI 1811253677
Payments from drug & device makers
Across 1,359 payments — averaging $274.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$253K
- AbbVie$48K
- Novartis$25K
- UCB, Inc.$21K
- Sobi, Inc$15K
- Johnson & Johnson$4K
- plus $8K from 28 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 529 | $252,880 |
| AbbVie | 232 | $47,866 |
| Novartis | 61 | $24,812 |
| UCB, Inc. | 100 | $21,235 |
| Sobi, Inc | 24 | $14,909 |
| Johnson & Johnson(2 entities) | 69 | $3,591 |
| AstraZeneca(2 entities) | 54 | $2,997 |
| GSK | 81 | $1,075 |
| Pfizer | 45 | $863 |
| Lilly USA, LLC | 32 | $484 |
| Mallinckrodt Hospital Products Inc. | 17 | $399 |
| Sanofi | 17 | $342 |
| Aurinia Pharma U.S., Inc. | 11 | $226 |
| ANI Pharmaceuticals, Inc. | 12 | $224 |
| Radius Health, Inc. | 12 | $219 |
| Organon | 12 | $216 |
| Boehringer Ingelheim | 10 | $190 |
| E.r. Squibb & Sons, L.L.C. | 11 | $184 |
| Medtronic | 2 | $179 |
| Kestra Medical Technology Services, Inc. | 1 | $133 |
| Actelion Pharmaceuticals US, Inc. | 5 | $128 |
| Impulse Dynamics (USA) Inc. | 1 | $90 |
| Fresenius Kabi USA, LLC | 3 | $70 |
| Biocon Biologics Inc | 3 | $60 |
| Ferring Pharmaceuticals Inc. | 2 | $47 |
| Janssen Scientific Affairs, LLC | 5 | $36 |
| Vertos Medical, Inc. | 1 | $24 |
| Nevro Corp. | 1 | $19 |
| Hikma Pharmaceuticals USA | 1 | $18 |
| Abbott | 1 | $17 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
| Genentech USA, Inc. | 1 | $14 |
| Sandoz | 1 | $13 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $12 |
How this compares
$373,586 in reported general payments places this provider in the 80th percentile of 102 rheumatology providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other rheumatology in Gilbert
- Joon Hee LimGilbert$4.5M
- Daniel KreutzGilbert$2.6M
- Michael FairfaxGilbert$272K
- Shiva MalatyGilbert$4K
- Mona AminGlendale$5.5M
- Nehad SolomanPhoenix$4.8M
- John TesserPhoenix$4.8M
- Andrew SharobeemGlendale$4M
- Swati BharadwajPhoenix$3.4M
- Amer Al-KhoudariChandler$3.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.